Daniell Richard

Exec. VP, European Commercial

1 company

Weak

Trades Analyzed

12M Win Rate

7.1%

Avg 3M Return

-5.7%

Avg 12M Return

-40.2%

Daniell Richard is an Exec. VP, European Commercial at TEVA PHARMACEUTICAL INDUSTRIES LTD. Recent SEC Form 4 filings include 0 buys and 10 sells.

Estimated insider holdings value: $5.3M based on current market prices.

Holdings by Company

TEVADec 9, 2025

Current Shares148.8K

Value$5.32M

Net Activity-979,517

Bought: 0Sold: 979.5K

Showing 10 filings (page 3)

Date	Ticker	Role	Type	Shares	Price	Value	Chg%
Feb 10, 2020	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	6,199	$12.24	$75,886.30	-41.9%
Sep 18, 2019	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	1,176	$7.82	$9,196.67	-41.2%
Sep 9, 2019	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	333	$7.16	$2,384.28	-47.8%
Mar 18, 2019	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	1,297	$16.64	$21,588.05	-100%
Mar 12, 2019	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	715	$15.69	$11,218.21	-100%
Mar 4, 2019	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	2,098	$16.88	$35,423.47	-100%
Sep 18, 2018	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	2,488	$23.69	$58,943.21	-100%
Sep 10, 2018	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	696	$21.25	$14,790.14	-100%
Mar 19, 2018	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	1,297	$17.89	$23,205.92	-100%
Mar 12, 2018	TEVA Teva Pharmaceutical Industries Ltd	Exec. VP, European Commercial	Sale+OE	714	$19.50	$13,921.57	-100%